文献速递围术期管理与 ERAS

医院手术量对再次冠状动脉旁路移植术结局的影响

Association of hospital volume with outcomes for reoperative coronary artery bypass grafting.
PubMed 文献 · Surgery · 2025-05-28

基于美国2016-2021年全国再入院数据库约47万例择期孤立CABG住院患者,5.0%为再次手术。再次手术与感染、血栓栓塞和卒中风险升高及费用增加相关,但在高容量中心再次手术仍与主要并发症和费用增加相关,提示病例量不能消除再次手术的风险。

要点

  • 再次CABG患者感染、血栓栓塞和卒中风险显著高于初次手术。
  • 再次CABG与更高住院费用相关,调整后β +$9,845。
  • 高容量中心再次CABG仍与主要并发症和费用增加相关。

核心结论

  • 再次冠状动脉旁路移植术后的主要围术期结局风险增加,且在高容量中心依然存在。

研究设计与样本

  • 回顾性队列研究,查询2016-2021年Nationwide Readmissions Database,纳入成人择期孤立CABG住院患者约470,546例,再次CABG占5.0%。

主要发现

  • 再次CABG患者年龄更大(70 vs 67岁,P < .001)、女性比例更高(26.7 vs 21.7%,P < .001)、Elixhauser合并症指数更高(5 vs 4,P < .001)。
  • 风险调整后,再次CABG与院内死亡率无显著关联(aOR 0.87,95%CI 0.74-1.03)。
  • 再次CABG与感染(aOR 1.72,95%CI 1.60-1.85)、血栓栓塞(aOR 1.85,95%CI 1.45-2.36)、卒中(aOR 1.35,95%CI 1.12-1.64)风险升高相关。
  • 高容量中心再次CABG占5.1%,再次手术与主要并发症(aOR 1.19,95%CI 1.12-1.27)和住院费用增加(β +$6,782,95%CI 5,725-7,837)相关。

临床怎么用

  • 再次CABG患者应加强围术期感染、血栓栓塞和卒中的预防与监测。
  • 高容量中心不应被视为消除再次CABG风险的保证,仍需优化围术期管理路径。

局限性

  • 研究为回顾性数据库分析,可能存在未测量混杂。
  • 仅纳入择期孤立CABG住院患者,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Outcomes following reoperative coronary artery bypass graft surgery are widely underexplored. Evaluating a contemporary national cohort, we assessed acute clinical and financial sequelae following reoperative coronary artery bypass graft surgery at the patient and hospital levels. METHODS: The 2016-2021 Nationwide Readmissions Database was queried to identify all adult (≥18 years) hospitalizations for elective isolated coronary artery bypass graft surgery. Patients with a history of coronary artery bypass graft surgery were categorized as ReOp (others: Non-ReOp). Centers in the highest quartile were considered high-volume centers. Multivariable regression models were built to assess the independent association of ReOp with clinical and financial outcomes. RESULTS: Of ∼470,546 patients, 5.0% were classified as ReOp. On average, ReOp was older (70 [63-76] vs 67 years [60-73], P < .001), more often female (26.7 vs 21.7%, P < .001), and of a higher Elixhauser comorbidity index (5 [4-7] vs 4 [3-5], P < .001). Following risk adjustment, ReOp was linked with comparable likelihood of in-hospital mortality (adjusted odds ratio 0.87, 95% confidence interval 0.74-1.03). However, ReOp faced greater odds of infection (adjusted odds ratio 1.72, 95% confidence interval 1.60-1.85), thromboembolism (1.85, 1.45-2.36), and stroke (1.35, 1.12-1.64). ReOp was also linked with greater costs (β +$9,845, 95% CI 8,888-0,802). At high-volume centers, 5.1% of coronary artery bypass graft surgery recipients were ReOp. Reoperation was associated with greater adjusted odds of major complications (adjusted odds ratio 1.19, 95% confidence interval 1.12-1.27) and increased hospitalization expenditures (β +$6,782, 95% confidence interval 5,725-7,837). CONCLUSION: The increased risk of facing major perioperative outcomes following reoperative coronary artery bypass graft surgery persists at centers despite case volume. Further studies are needed to develop optimal perioperative care pathways for these patients.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Khoraminejad B, Sakowitz S, Coaston T, et al. Association of hospital volume with outcomes for reoperative coronary artery bypass grafting. Surgery. 2025. PMID: 40440792. doi:10.1016/j.surg.2025.109441

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。